Giuseppe Pettinato, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organoids | 5 | 2023 | 739 | 2.030 |
Why?
|
| Induced Pluripotent Stem Cells | 8 | 2022 | 1883 | 2.000 |
Why?
|
| Embryoid Bodies | 6 | 2022 | 64 | 1.890 |
Why?
|
| Hepatocytes | 6 | 2023 | 1247 | 1.150 |
Why?
|
| Endothelial Cells | 4 | 2023 | 3584 | 0.760 |
Why?
|
| Cell Culture Techniques | 4 | 2016 | 1652 | 0.740 |
Why?
|
| Liver Failure, Acute | 2 | 2016 | 183 | 0.570 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 328 | 0.470 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 545 | 0.420 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 291 | 0.410 |
Why?
|
| Cell Differentiation | 7 | 2022 | 11641 | 0.380 |
Why?
|
| Antigens, Differentiation | 1 | 2014 | 919 | 0.380 |
Why?
|
| Liver | 2 | 2023 | 7562 | 0.350 |
Why?
|
| Embryonic Development | 1 | 2015 | 718 | 0.340 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1657 | 0.320 |
Why?
|
| Panax | 2 | 2018 | 27 | 0.300 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1241 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2900 | 0.250 |
Why?
|
| Repressor Proteins | 1 | 2016 | 2968 | 0.250 |
Why?
|
| Cell Transplantation | 2 | 2019 | 473 | 0.240 |
Why?
|
| Oligopeptides | 2 | 2018 | 1192 | 0.200 |
Why?
|
| Sarcoma, Kaposi | 1 | 2023 | 375 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5696 | 0.150 |
Why?
|
| Liver Failure | 1 | 2019 | 252 | 0.140 |
Why?
|
| Microscopy | 1 | 2021 | 901 | 0.130 |
Why?
|
| Plant Proteins | 1 | 2018 | 374 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1336 | 0.120 |
Why?
|
| Teratoma | 1 | 2018 | 401 | 0.120 |
Why?
|
| Germ Layers | 1 | 2014 | 72 | 0.110 |
Why?
|
| Bioreactors | 1 | 2015 | 244 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2017 | 496 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 213 | 0.110 |
Why?
|
| Models, Animal | 1 | 2019 | 2120 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 734 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2018 | 1181 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1927 | 0.090 |
Why?
|
| Chromatin | 1 | 2021 | 2980 | 0.080 |
Why?
|
| Intestines | 1 | 2018 | 1906 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2210 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 292 | 0.070 |
Why?
|
| Humans | 14 | 2023 | 765968 | 0.070 |
Why?
|
| Sperm Motility | 1 | 2009 | 265 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 4270 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2394 | 0.070 |
Why?
|
| Candidiasis | 1 | 2009 | 371 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3081 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20124 | 0.060 |
Why?
|
| Spermatozoa | 1 | 2009 | 629 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 632 | 0.060 |
Why?
|
| Rats | 2 | 2016 | 23707 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2015 | 18973 | 0.050 |
Why?
|
| Macrophages | 1 | 2017 | 5772 | 0.050 |
Why?
|
| Cell Line | 1 | 2014 | 15543 | 0.040 |
Why?
|
| Animals | 6 | 2018 | 168764 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 366 | 0.040 |
Why?
|
| Whole-Body Irradiation | 1 | 2018 | 438 | 0.040 |
Why?
|
| Mice | 4 | 2018 | 81819 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18293 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 175 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2018 | 562 | 0.030 |
Why?
|
| Centrosome | 1 | 2018 | 209 | 0.030 |
Why?
|
| Neoplasms | 2 | 2023 | 22340 | 0.030 |
Why?
|
| Rats, Nude | 1 | 2015 | 105 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2018 | 852 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2017 | 579 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2018 | 863 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9514 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 577 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2017 | 1520 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1555 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1896 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 1811 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 238 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6220 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 610 | 0.020 |
Why?
|
| Body Weight | 1 | 2018 | 4622 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3222 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3141 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 1663 | 0.010 |
Why?
|
| Incidence | 1 | 2023 | 21480 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7421 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10429 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8611 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6203 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10261 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5881 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 74840 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65188 | 0.000 |
Why?
|
| Male | 2 | 2015 | 363698 | 0.000 |
Why?
|
| Female | 1 | 2017 | 396112 | 0.000 |
Why?
|